Treatments for Leber's hereditary optic neuropathy

Drugs of the Future

Volumn 35, Issue 2, 2010, Pages 129-133

  Rosenfeld, A E ^a   Sadun, Alfredo A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; BRIMONIDINE; CYANOCOBALAMIN; DECYTUBIQUINONE; ETHAMBUTOL; GLUTATHIONE; IDEBENONE; METHYLPREDNISOLONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RIBOFLAVIN; ROTENONE; TROLOX C; UBIDECARENONE; UBIQUINONE; UNCLASSIFIED DRUG;

ARTICLE; CENTRAL SCOTOMA; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; GENETIC DISORDER; HETEROPLASMY; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; MITOCHONDRIAL DNA REPLICATION; OPTIC NERVE ATROPHY; OPTICAL COHERENCE TOMOGRAPHY; OXIDATIVE PHOSPHORYLATION; POINT MUTATION; RESPIRATORY CHAIN; RETINA GANGLION CELL; TELANGIECTASIA; TOPICAL TREATMENT; VISUAL IMPAIRMENT;

EID: 84930542991     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2010.035.02.1464998     Document Type: Article

References (33)

1. Carelli, V., Ross-Cisneros, F.N., Sadun, A.A. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res 2004,23(1):53-89. (Pubitemid 38177172)
2. Sadun, A.A., Carelli, V., Salomao, S.R. et al. Extensive investigation of a large Brazilian pedigree of 11778/haplogroup J Leber hereditary optic neuropathy. Am J Ophthalmol 2003,136(2):231-8.
3. Fraser, J.A., Biousse, V., Newman, N.J. The neuro-ophthalmology of mitochondrial disease. Survey of Ophthalmology, In press.
4. Savini, C., Barboni, P., Valentino, M.L. et al. Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber's hereditary optic neuropathy mutations. Ophthalmology 2005,112(1):127-31. (Pubitemid 40075331)
5. Barboni, P., Savini, C., Valentino, M.L. et al. Retinal nerve fiber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy. Ophthalmology 2005,112(1):120-6.
6. Sadun, A.A., Carelli, V., Salomao, S.R. et al. A very large Brazilian pedigree with 11778 Leber's hereditary optic neuropathy. Trans Am Ophthalmol Soc 2002,100:169-78.
7. Sadun, A.A., Win, RH., Ross-Cisneros, F.N., Walker, S.O., Carelli, V. Leber's hereditary optic neuropathy differentially affects smaller axons in the optic nerve. Trans Am Ophthalmol Soc 2000,98:223-32.
8. Gualtieri, M., Bandeira, M., Hamer, R.D. et al. Psychophysical analysis of contrast processing segregated into magnocellular and parvocellulor systems in asymptomatic carriers of 11778 Leber's hereditary optic neuropathy. Vis Neurosci 2008,25(3):469-74.
9. Sadun, A.A., Salomao, S.R., Berezovsky, A. et al. Subclinical carriers and conversions in Leber hereditary optic neuropathy: A prospective psychophysical study. Trans Am Ophthalmol Soc 2006,104:51-61.
10. Ventura, D.F., Gualtieri, M., Oliveira, A.G. et al. Male prevalence of acquired color vision defects in asymptomatic carriers of Leber's hereditary optic neuropathy. Invest Ophthalmol Vis Sci 2007,48(5):2362-70.
11. Sadun, F., De Negri, A.M., Carelli, V. et al. Ophthalmologic findings in a large pedigree of 11778/haplogroup J Leber hereditary optic neuropathy. Am J Ophthalmol 2004,137(2):271-7.
12. Quiros, P.A., Torres, R.J., Salomao, S. et al. Colour vision defects in asymptomatic carriers of the Leber's hereditary optic neuropathy (LHON) mtDNA 11778 mutation from a large Brazilian LHON pedigree: A case-control study. Br J Ophthalmol 2006,90(2):150-3.
13. Ventura, D.F., Quiros, P., Carelli, V. et al. Chromatic and luminance contrast sensitivities in asymptomatic carriers from a large Brazilian pedigree of 11778 Leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci 2005,46(12):4809-14. (Pubitemid 44264588)
14. Shankar, S.P., Fingert, J.H., Carelli, V. et al. Evidence for a novel x-linked modifier locus for Leber hereditary optic neuropathy. Ophthalmic Genet 2008,29(1):17-24. (Pubitemid 351431243)
15. Kerrison, J.B., Miller, N.R., Hsu, F. et al. A case-control study of tobacco and alcohol consumption in Leber hereditary optic neuropathy. Am J Ophthalmol 2000,130(6):803-12. (Pubitemid 32000863)
16. Kirkman, M.A., Yu-Wai-Man, P., Korsten, A. et al. Gene-environment interactions in Leber hereditary optic neuropathy. Brain 2009,132(Pt. 9):2317-26.
17. Sanchez, R.N., Smith, A.J., Carelli, V., Sadun, A.A., Keltner, J.L. Leber hereditary optic neuropathy possibly triggered by exposure to tire fire. J Neuroophthalmol 2006,26(4):268-72. (Pubitemid 46066881)
18. De Marinis, M. Optic neuropathy after treatment with anti-tuberculous drugs in a subject with Leber's hereditary optic neuropathy mutation. J Neurol 2001,248(9):818-9. (Pubitemid 32802121)
19. Ikeda, A., Ikeda, T., Ikeda, N., Kawakami, Y., Mimura, O. Leber's hereditary optic neuropathy precipitated by ethambutol. Jpn J Ophthalmol 2006, 50(3):280-3. (Pubitemid 43882006)
20. Newman, N.J., Biousse, V., David, R. et al. Prophylaxis for second eye involvement in Leber hereditary optic neuropathy: An open-labeled, non-randomized multicenter trial of topical brimonidine purite. Am J Ophthalmol 2005,140(3):407-15.
21. Wheeler, L., WoldeMussie, E., Lai, R. Role of alpha-2 agonists in neuroprotection. Surv Ophthalmol 2003,48(Suppl. 1):S47-51.
22. Lai, R.K., Chun, T., Hasson, D., Lee, S., Mehrbod, F., Wheeler, L. Alpha-2 adrenoceptor agonist protects retinal function after acute retinal ischemic injury in the rat. Vis Neurosci 2002,19(2):175-85. (Pubitemid 35230993)
23. Pott, J.W., Wong, K.H. Leber's hereditary optic neuropathy and vitamin B12 deficiency. Graefes Arch Clin Exp Ophthalmol 2006,244(10):1357-9.
24. Ghelli, A., Porcelli, A.M., Zanna, C., Martinuzzi, A., Carelli, V., Rugolo, M. Protection against oxidant-induced apoptosis by exogenous glutathione in Leber hereditary optic neuropathy cybrids. Invest Ophthalmol Vis Sci 2008,49(2):671-6.
25. Sala, G., Trombin, F., Beretta, S. et al. Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids. J Neurosci Res 2008,86(15):3331-7.
26. A randomized, double-blind, placebo-controlled trial of curcumin in Leber's hereditary optic neuropathy (LHON) (NCT00528151). ClinicalTrials.gov, January 15, 2010.
27. Huang, C.C., Kuo, H.C., Chu, C.C., Kao, L.Y. Rapid visual recovery after coenzyme q10 treatment of Leber hereditary optic neuropathy. J Neuroophthalmol 2002,22(1):66.
28. Stone, E.M., Newman, N.J., Miller, N.R., Johns, D.R., Lott, M.T., Wallace, D.C. Visual recovery in patients with Leber's hereditary optic neuropathy and the 11778 mutation. J Clin Neuroophthalmol 1992,12(1):10-4.
29. Carelli, V., Barboni, P., Zacchini, A. et al. Leber's hereditary optic neuropathy (LHON) with 14484/ND6 mutation in a North African patient. J Neurol Sei 1998,160(2):183-8. (Pubitemid 28522546)
30. Barnils, N., Mesa, E., Munoz, S., Ferrer-Artola, A., Arruga, J. Response to idebenone and multivitamin therapy in Leber's hereditary optic neuropathy. Arch Soc Esp Oftalmol 2007,82(6):377-80.
31. Mashima, Y., Kigasawa, K., Wakakura, M., Oguchi, Y. Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy? J Neuroophthalmol 2000,20(3):166-70.
32. Eng, J.G., Aggarwal, D., Sadun, A.A. Idebenone treatment in patients with Leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci 2009, 50(Suppl):1440.
33. Guy, J., Qi, X., Koilkonda, R.D. et al. Efficiency and safety of AAV-mediated gene delivery of the human ND4 complex I subunit in the mouse visual system. Invest Ophthalmol Vis Sci 2009,50(9):4205-14.